2. Poole CJ, Perren T, Gawande S, et al. Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer. Int J Gynecol Cancer. 2006;16(2):507-514. doi:10.1111/j.1525-1438.2006.00466.x
3. Maurel J, López-Pousa A, de Las Peñas R, et al. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas. J Clin Oncol. 2009;27(11):1893-1898. doi:10.1200/JCO.2008.19.2930
